FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:1009-1010 October 2, 1997 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Holleman, F. PubMed Citation

To the Editor: Insulin lispro is a new insulin analogue that acts more rapidly than regular insulin. To date, there are no reports on fetal outcomes after therapy with insulin lispro in pregnant women; indeed, pregnancy has been a contraindication for its use in all of the drug studies.¹

We report on two primiparous women treated with NPH insulin and insulin lispro during pregnancy. Both had well-controlled insulin-dependent diabetes mellitus with no evidence of complications at the time of conception. Excellent glycemic control was maintained throughout their pregnancies, with hemoglobin A _1c values (measured every three months) of less than 7.0 . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Jovanovic, L., Pettitt, D. J. (2007). Treatment With Insulin and Its Analogs in Pregnancies Complicated by Diabetes. Diabetes Care 30: S220-S224 [Full Text]  
• Trujillo, A. L. (2007). Insulin Analogs and Pregnancy. Diabetes Spectr. 20: 94-101 [Abstract] [Full Text]  
• (2004). Update on insulin analogues. DTB 42: 77-80 [Abstract] [Full Text]  
• Boskovic, R., Feig, D. S., Derewlany, L., Knie, B., Portnoi, G., Koren, G. (2003). Transfer of Insulin Lispro Across the Human Placenta: In vitro perfusion studies. Diabetes Care 26: 1390-1394 [Abstract] [Full Text]  
• Bhattacharyya, A., Brown, S., Hughes, S., Vice, P.A. (2001). Insulin lispro and regular insulin in pregnancy. QJM 94: 255-260 [Abstract] [Full Text]